Latest available resultsQuarter ended April 30, 202610-Q · June 5, 2026
Filed with the SECCOOPER COMPANIES, INC.
COOHealthcare
Next reportSeptember 9, 2026after close · Analyst forecast 1.129 $/share
Revenue
$1.08B
▲ +7.9% vs prior year% YoY
Net income
−$77.90M
▼ -188.8% vs prior year% YoY
EPS
-0.40$
▼ -190.9% vs prior year% YoY
Net margin
-7.2%
▼ -16.0 percentage points vs prior year pp YoY
Revenue▲ +7.9 %
Margins (% of revenue)GrossOperatingNet
Net income▼ -188.8 %
EPS▼ -190.9 %
View financial tableQuarter ended April 30, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $1.08B | |
| Gross profit | $735.40M | 68.0 % |
| Operating income | −$31.00M | -2.9 % |
| Net income | −$77.90M | -7.2 % |
| R&D | $42.50M | 3.9 % |
| EPS (diluted) | -0.40 $ | |
| Balance sheet | ||
| Assets | $12.48B | |
| Liabilities | $4.24B | |
| Equity | $8.24B | |
| Cash | $138.80M | |
| Capital | ||
| Shares outstanding | 195.03M | as of 2026-06-01 |
| Public float | — | |